135 related articles for article (PubMed ID: 9589357)
1. Polyamine measurements in the uterine cervix.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WK; Lotan R; Wharton JT; Hong WK; Nishioka K
J Cell Biochem Suppl; 1997; 28-29():125-32. PubMed ID: 9589357
[TBL] [Abstract][Full Text] [Related]
2. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
3. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Boiko IV; Mitchell MF; Hu W; Pandey DK; Mathevet P; Malpica A; Hittelman WN
Clin Cancer Res; 1998 Jun; 4(6):1383-91. PubMed ID: 9626454
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention trials and surrogate end point biomarkers in the cervix.
Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.
Meyskens FL; Simoneau AR; Gerner EW
Recent Results Cancer Res; 2014; 202():115-20. PubMed ID: 24531785
[TBL] [Abstract][Full Text] [Related]
8. The role of polyamine depletion and accumulation of decarboxylated S-adenosylmethionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine.
Pegg AE
Biochem J; 1984 Nov; 224(1):29-38. PubMed ID: 6439194
[TBL] [Abstract][Full Text] [Related]
9. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
10. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
Gerner EW; Garewal HS; Emerson SS; Sampliner RE
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):325-30. PubMed ID: 8061581
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of acetyl derivatives of polyamines in cultured polyamine-deficient rat hepatoma cells.
Mamont PS; Seiler N; Siat M; Joder-Ohlenbusch AM; Knödgen B
Med Biol; 1981 Dec; 59(5-6):347-53. PubMed ID: 6803078
[TBL] [Abstract][Full Text] [Related]
13. DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia.
Boiko IV; Mitchell MF; Pandey DK; White RA; Hu W; Malpica A; Nishioka K; Boone CW; Atkinson EN; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):849-55. PubMed ID: 9332769
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
15. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cervical intraepithelial neoplasia 2, 3 and cancer on the uterine cervix.
Pretorius RG; Zhang X; Belinson JL; Zhang WH; Ren SD; Bao YP; Qiao YL
J Low Genit Tract Dis; 2006 Jan; 10(1):45-50. PubMed ID: 16378031
[TBL] [Abstract][Full Text] [Related]
17. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis.
Tipnis UR; He GY; Li S; Campbell G; Boor PJ
Cardiovasc Pathol; 2000; 9(5):273-80. PubMed ID: 11064274
[TBL] [Abstract][Full Text] [Related]
19. Polyamine metabolism in Pneumocystis carinii.
Lipschik GY; Masur H; Kovacs JA
J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
[TBL] [Abstract][Full Text] [Related]
20. Polyamine depletion and growth inhibition of Cryptococcus neoformans by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
Mycopathologia; 1990 Oct; 112(1):27-32. PubMed ID: 2250691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
